Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 12 of 23

Cannabis Science Creates A New Policy Advisory Board With Prominent Denver Attorney, Brian Vicente As First Member And Will Expand Its Scientific Advisory Board As Expert Support for The Company Increases From Those Most Knowledgeable About the Importance

Created on 2018-06-11 22:00:06

Cannabis Science Goes Live with Two National Business Radio Show Interviews Beginning Tomorrow Covering the Nation with Stu Taylor's "Equity Strategies Show"

Created on 2018-06-11 21:59:01

Cannabis Science Updates Progress For Its Phytocannabinoid Pharmaceutical Products To Help Reduce ARDS-Associated Deaths From Both The Avian And Swine

Created on 2018-06-11 21:57:59

Cannabis Science Signs Leading Points Corporation To Advance State and Federal Agencies Programs

Created on 2018-06-11 21:57:01

Cannabis Science Appoints Ritchard L. Fishman, M.D., Senior Medical Advisor As Its Second Member of Its Scientific Advisory Board

Created on 2018-06-11 21:56:05

Cannabis Science Reports On Two Cannabis-Based Drug Release Programs

Created on 2018-06-11 21:54:40

Cannabis Science Appoints Dr. Mitch Earleywine Renowned Psychology Expert As Its First Member Of Its New Scientific Advisory Board

Created on 2018-06-11 21:53:27

Dr. Robert Melamede Ph.D. and Cannabis Science Inc. Respond to an ABC News Report

Created on 2018-06-11 21:52:33

Today Dr. Melamede Makes A Statement Addressing Veterans Coping With Post Traumatic Stress Disorder (PTSD) A National Disgrace; Cannabis Science To Launch A Program To Work With Veterans Who Use Medical Cannabis To Cope With PTSD

Created on 2018-06-11 21:50:42

Cannabis Science Receives FDA Industry Guidelines for Mapping Out Its Initial Drugs Offerings for FDA Submission and Testing

Created on 2018-06-11 21:49:47

Cannabis Science to Apply to the FDA to Utilize Their Fast Track Procedures to Help Speed the Approval of Its Cannabinoid Medicines in Treatment of H1N1 Swine Flu as AP Report Predicts Swine Flu Could Hit up to 40 Percent in the USA

Created on 2018-06-11 21:48:52

Today's CNN Pandemic Report on H1N1 Pushes Cannabis Science to Move Faster to Release Its Anti-Inflammatory Cannabis Drug as Similarities Between 2009 and Deadly 1918 Influenza Pandemic Cause Concern; FDA Approved Drugs Needed Now to Meet This Urgent Situ

Created on 2018-06-11 21:47:55

Today's Wall Street Journal Reports on Cannabis Science Inc. in Article on Booming Medical Cannabis Industry; Indicates Great Demand for Products From a Patient Oriented Company

Created on 2018-06-11 21:46:33

CSI President Dr. Robert Melamede Testified Yesterday at Denver Hearing Which Stopped Attempt to Restrict Patients' Access to Medical Marijuana; Cannabis Science Plans for End of Marijuana Prohibition

Created on 2018-06-11 21:45:25

Dr. Melamede Confirms Pre-IND Procedures Are in Motion for Pre-IND Meeting With the FDA and Plans Corporate Headquarters Move to Colorado Springs, Colorado

Created on 2018-06-11 21:33:20

The New Cannabis Science President & CEO Dr. Melamede Reports FDA Progress Plans And New Management Team Objectives for its Cannabis Formulations

Created on 2018-06-11 21:32:14

CBIS Appoints Dr. Robert Melamede, Ph.D., Former Chairman of the Biology Department at University of Colorado, Colorado Springs, As President & CEO

Created on 2018-06-11 21:31:10

Cannabis Science Enters into Investor Relations Agreement

Created on 2018-06-11 21:30:09

A New Audio Interview Featuring Cannabis Science CEO, Steve Kubby, is Now at SmallCapVoice.com

Created on 2018-06-11 21:29:09

Cannabis Science Development Team Recommends Patent Filings for Its Cannabis Processing and Drug Delivery Systems

Created on 2018-06-11 21:28:00

  • Start
  • Prev
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.